rs397516904
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM5PP2PP3_ModeratePP5_Very_Strong
The NM_001374258.1(BRAF):c.785A>G(p.Gln262Arg) variant causes a missense change involving the alteration of a conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q262K) has been classified as Likely pathogenic.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
BRAF
NM_001374258.1 missense
NM_001374258.1 missense
Scores
6
5
2
Clinical Significance
Conservation
PhyloP100: 7.97
Genes affected
BRAF (HGNC:1097): (B-Raf proto-oncogene, serine/threonine kinase) This gene encodes a protein belonging to the RAF family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERK signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene, most commonly the V600E mutation, are the most frequently identified cancer-causing mutations in melanoma, and have been identified in various other cancers as well, including non-Hodgkin lymphoma, colorectal cancer, thyroid carcinoma, non-small cell lung carcinoma, hairy cell leukemia and adenocarcinoma of lung. Mutations in this gene are also associated with cardiofaciocutaneous, Noonan, and Costello syndromes, which exhibit overlapping phenotypes. A pseudogene of this gene has been identified on the X chromosome. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 13 ACMG points.
PM5
?
Other missense variant is known to change same aminoacid residue: Variant chr7-140801488-G-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 40352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP2
?
Missense variant where missense usually causes diseases, BRAF
PP3
?
MetaRNN computational evidence supports a deleterious effect, 0.932
PP5
?
Variant 7-140801487-T-C is Pathogenic according to our data. Variant chr7-140801487-T-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 180723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BRAF | NM_001374258.1 | c.785A>G | p.Gln262Arg | missense_variant | 6/20 | ENST00000644969.2 | |
BRAF | NM_004333.6 | c.785A>G | p.Gln262Arg | missense_variant | 6/18 | ENST00000646891.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BRAF | ENST00000644969.2 | c.785A>G | p.Gln262Arg | missense_variant | 6/20 | NM_001374258.1 | |||
BRAF | ENST00000646891.2 | c.785A>G | p.Gln262Arg | missense_variant | 6/18 | NM_004333.6 | P4 |
Frequencies
GnomAD3 genomes ? Cov.: 32
GnomAD3 genomes
?
Cov.:
32
GnomAD4 exome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 1461728Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727168
GnomAD4 exome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
AC:
0
AN:
1461728
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
727168
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? Cov.: 32
GnomAD4 genome
?
Cov.:
32
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, no assertion criteria provided | clinical testing | Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center | Jan 15, 2015 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 17, 2023 | Multiple missense variants at this residue [p.(Q262K) and p.(Q262P)] have been reported in association with BRAF-related RASopathy in patients previously tested at GeneDx and in the published literature (Ciara et al., 2015; Schulz et al., 2008); Missense variants in this gene are often considered pathogenic (HGMD); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 24957944, 15488754, 16439621, 15520807, 17603483, 29493581, 24803665, 17704260, 19953625, 29907801, 30050098, 32185055, 25463315, 18042262) - |
RASopathy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Invitae | Aug 08, 2015 | Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). For these reasons, this variant has been classified as Likely Pathogenic. Two other missense substitutions at this codon (p.Gln262Lys and p.Gln262Pro) have been reported as de novo mutations in patients affected with cardio-facio-cutaenous syndrome (PMID: 18042262, 25463315). This suggests that the glutamine residue is important for BRAF protein function. This variant was reported in an individual affected with cardio-facio-cutaneous syndrome (PMID: 17704260) and in an individual affected with Noonan syndrome (PMID: 19953625). Full parental testing was not performed in either cases, but were suspected to be sporadic. This variant is not present in population databases and has been reported in the literature. ClinVar also contains an entry for this variant (RCV000157699). This sequence change replaces glutamine with arginine at codon 262 of the BRAF protein (p.Gln262Arg). The glutamine residue is highly conserved and there is a small physicochemical difference between glutamine and arginine. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
Cadd
Pathogenic
Dann
Uncertain
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Uncertain
D
MutationTaster
Benign
D
PrimateAI
Pathogenic
D
Polyphen
0.48
.;.;P;.
Vest4
0.90
MutPred
Gain of MoRF binding (P = 0.0298);Gain of MoRF binding (P = 0.0298);Gain of MoRF binding (P = 0.0298);Gain of MoRF binding (P = 0.0298);
MVP
0.99
MPC
1.6
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at